申请人:Boehringer Ingelheim International GmbH
公开号:EP1645556A1
公开(公告)日:2006-04-12
The invention relates to arylpiperazine-benzoylamide derivatives of formula (I)
wherein A, X1, X2, n and R1 to R10 are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation and the use thereof for preparing a pharmaceutical composition.
该发明涉及式(I)的芳基哌嗪-苯甲酰胺衍生物,其中A、X1、X2、n和R1至R10的定义如权利要求1所述,适用于治疗由细胞过度或异常增殖特征的疾病,并用于制备药物组合物。